Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, presented detailed data on its lentiviral vector retargeting ...

Rising demand for gene and cell therapies, expanding mRNA vaccine pipelines, and increasing investments in GMP-compliant manufacturing facilities are driving growth in the viral vectors and plasmid ...

Wacom today released a new Android update for the Wacom MovinkPad series that introduces ibisPaint X as a pre-installed app ...